The healthiest countries in the world
Mediterranean diet seems to be good for health. 169 economies were scrutinized
Receive up-to-date information about the company directly via push notification
Nutrition, sanitation and access to clean water were assessed by the Bloomberg Healthiest Country Index. Spain took first place, replacing Italy as the runner-up. Iceland came third, Japan fourth. Switzerland reached fifth place, followed by Sweden and Norway. Then Singapore, Australia and Israel follow. Germany did not even make it into the top 20, but had to settle for 23rd place.
Spaniards can therefore expect the highest life expectancy in Europe. A healthy diet is an extremely important basis. Which, unfortunately, is not guaranteed in many areas of the world. Food must be processed and preserved. Preservation is the business of EnWave, for example.
The Canadian EnWave - https://www.youtube.com/watch?v=-aqWUa7hVCQ - drains organic materials, food, pharmaceutical products and medical cannabis with its innovative method. EnWave agrees commercial licenses with partner companies. They use EnWave's REV™ technology to dry their products. EnWave's customers include Bonduelle, Nestlé, Kellogg´s and Merck (Pharma).
Health is also increasingly being taken care of by companies that manufacture and distribute cannabis products. The European cannabis market is growing steadily. Germany also has enormous potential. But not only the medical field, also the leisure use increases, because the plant is legalized in more and more countries. Canada has certainly played a pioneering role in this.
RavenQuest BioMed - https://www.youtube.com/watch?v=UgUsP8r2KiA=15s - is a Canadian cannabis producer that ensures the growing supply of cannabis. The company's most recent business success is obtaining permission to export cannabis to Australia. There Medcan Australia will process the plants into medical cannabis.
Current company information and press releases from EnWave (
www.resource-capital.ch/de/unternehmen/enwave-corp/)
and RavenQuest BioMed (www.resource-capital.ch/de/unternehmen/ravenquest-biomed-inc/).
In accordance with §34 WpHG I would like to point out that partners, authors and employees may hold shares in the respective companies and that there is therefore a potential conflict of interest. No guarantee for the translation into German. Only the English version of these messages is valid.
Disclaimer: The information provided does not constitute any form of recommendation or advice. The risks involved in securities trading are expressly pointed out. No liability can be accepted for damages arising from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. For the correctness of all contents however no guarantee is taken over. Despite the greatest care, I expressly reserve the right to make an error, particularly with regard to figures and prices. The information contained herein has been obtained from sources believed to be reliable, but does not claim to be accurate or complete. Due to judicial judgements the contents of linked external sides are to be answered for also (so among other things regional court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no express dissociation from these takes place. Despite careful content control, I do not assume any liability for the content of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: https://www.resource-capital.ch/de/disclaimer-agb/